Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02034344 · ClinicalTrials.gov registry record

A Study of Skin and Systemic Biomarkers In Patients With Active Cutaneous Lupus Erythematosus And In Healthy Volunteers

A clinical trial of Healthy and Lupus Erythematosus, Systemic, sponsored by Janssen Research & Development.

Completed
Registry status
77
Enrollment target
20
Study locations

NCT02034344 is a study of Healthy and Lupus Erythematosus, Systemic that has completed, run by Janssen Research & Development. The registered enrollment target is 77 participants, below the 647-participant average among 1,090 other Healthy trials with a reported enrollment target (88% lower). The trial reports 20 study locations across 9 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02034344, a study of Healthy and Lupus Erythematosus, Systemic, has completed, sponsored by Janssen Research & Development.

COMPLETED
Registry status
77 participants
Enrollment target
20
Study locations

Study Summary

The purpose of this study is to obtain skin, blood, and urine samples from patients with active cutaneous lupus lesions and from healthy participants.

Conditions Studied

Healthy Lupus Erythematosus, Systemic Lupus Erythematosus, Discoid Lupus Erythematosus, Cutaneous

Interventions

  • PROCEDURE Blood collection
  • PROCEDURE Skin biopsy
  • PROCEDURE Urine collection

Study Locations (20)

Other

  • - Berlin
  • - Kiel
  • - Chihuahua City
  • - Jalisco
  • - Mexico City
  • - Gdansk
  • - Krakow
  • - Wroclaw
  • - Taichung
  • - Taipei
  • - Leeds

Pennsylvania

  • - Duncansville
  • - Philadelphia

California

  • - La Jolla

Illinois

  • - Chicago

Massachusetts

  • - Boston

Michigan

  • - Lansing

New Jersey

  • - Neptune City

North Carolina

  • - Charlotte

Trial Details

FieldValue
Enrollment Target 77 participants
Start Date 2013-10
Est. Completion 2015-05

Sponsor

Janssen Research & Development

593 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT02034344

The ClinicalTrials.gov registry entry for NCT02034344 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 77 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 647-participant average among 1,090 other Healthy trials with a reported enrollment target (88% lower). The listed sponsor is Janssen Research & Development, which has 593 total studies on file at ClinicalTrials.gov.

The record links to 4 conditions, with Healthy appearing as the primary indexed condition, and to 3 interventions - of which Blood collection is the first listed.

NCT02034344 reports 20 study locations spanning 9 distinct geographic areas - top geographies include Other, Pennsylvania, California.

Frequently Asked Questions

What is clinical trial NCT02034344 about?

NCT02034344 is a clinical study titled "A Study of Skin and Systemic Biomarkers In Patients With Active Cutaneous Lupus Erythematosus And In Healthy Volunteers". The purpose of this study is to obtain skin, blood, and urine samples from patients with active cutaneous lupus lesions and from healthy participants.

What is the current status of trial NCT02034344?

This trial is currently completed. The enrollment target is 77 participants. The study started on 2013-10. Estimated completion is 2015-05.

What conditions does trial NCT02034344 study?

This clinical trial studies the following conditions: Healthy, Lupus Erythematosus, Systemic, Lupus Erythematosus, Discoid, Lupus Erythematosus, Cutaneous.

What interventions are being tested in trial NCT02034344?

The interventions under investigation include: Blood collection (PROCEDURE), Skin biopsy (PROCEDURE), Urine collection (PROCEDURE).

Who is sponsoring clinical trial NCT02034344?

This trial is sponsored by Janssen Research & Development, which has 593 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02034344 being conducted?

This trial has 20 study locations across California, Illinois, Massachusetts, Michigan, New Jersey. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Healthy

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Healthy

All registered trials for this condition

Lupus Erythematosus, Systemic

All registered trials for this condition

California

All trials with a study site in California

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.